Dec 1: 2 Strong Themes — Stem Cells, Gene Therapy & Genomics
2 strong themes — 1 recurred · 1 new. Top: Stem Cells +24.6%.
Average change by strong theme
Theme leaders · recent trend
| Theme | Leader | Change | Trend |
|---|---|---|---|
| Stem Cells | Macrogen | +29.95% | |
| Gene Therapy & Genomics | HLB Panagene | +23.64% |
On Dec 1, 2017, Stem Cells returned after a gap of 925 days, posting an average change of 24.6% with all 5 of its stocks closing higher.
Macrogen led with a 29.95% gain, while Chabiotech and Corestemchemon rose 29.94% and 29.81%. A same-day Korean news report tied the move to eased stem cell research rules.
The newly appearing Gene Therapy & Genomics theme had an average change of 14.63%, led by HLB Panagene at 23.64%. A Korean news report said the stock hit a 52-week high.
Today’s Strong Themes at a Glance
| # | Theme | Status | Avg. change | Up/Total | Leader |
|---|---|---|---|---|---|
| 1 | Stem Cells | recurred after 925 days | +24.6% | 5/5 | Macrogen |
| 2 | Gene Therapy & Genomics | new | +14.6% | 3/3 | HLB Panagene |
Theme by Theme
1. Stem Cells (recurred after 925 days)
- Episode: started 2017-12-01, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Macrogen 038290 | +29.9% | 35,800 | ★ |
Chabiotech 085660 | +29.9% | 17,032 | |
Corestemchemon 166480 | +29.8% | 10,089 | |
Medipost 078160 | +17.9% | 44,895 | |
HLB 028300 | +15.4% | 16,577 |
Related news
- [주목! 급등락 종목(12/1)] 줄기세포 규제 완화 소식에 우리들휴브레인 등 관련주 ‘上’ — 뉴스핌 (Korean)
- [ET투자뉴스]줄기세포 관련주테마, 차바이오텍, 파미셀 중심으로 강세 — 전자신문 (Korean)
- [특징주] 차바이오텍, 줄기세포 연구 규제 완화에 ‘강세’ — 뉴스핌 (Korean)
2. Gene Therapy & Genomics (new)
- Episode: started 2017-12-01, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
HLB Panagene 046210 | +23.6% | 8,160 | ★ |
Theragen Etex 066700 | +10.8% | 8,450 | |
LabGenomics 084650 | +9.5% | 1,939 |
Related news
- 파나진, 52주 신고가 — 헤럴드경제 (Korean)
- [fnRASSI]파나진(046210) 8.94% 상승 — 파이낸셜뉴스 (Korean)
- [바이오 진단장비 테마]파나진, SK바이오랜드 등 상승 — 헤럴드경제 (Korean)
Closing Thoughts
Both themes are on a streak of 1, so the open question is whether the rally lasts past a single session. Trading volume was heaviest in Chabiotech, at 14023133 shares.
One thing to watch is whether more news on stem cell research rules keeps that theme active. In genomics, Theragen Etex rose 10.75% and LabGenomics rose 9.49%, so the gains went beyond the leader.